|
Basic Characteristics of Mutations
|
|
Mutation Site
|
H275Y |
|
Mutation Site Sentence
|
Our findings suggest that this method provides a rapid tool for H275Y detection, with high sensitivity and potential benefit for patient care. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
NA |
|
Standardized Encoding Gene
|
NA
|
|
Genotype/Subtype
|
H1N1 |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Influenza A
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
oseltamivir |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
22000086
|
|
Title
|
Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory
|
|
Author
|
Bao JR,Huard TK,Piscitelli AE,Tummala PR,Aleemi VE,Coon SL,Master RN,Lewinski MA,Clark RB
|
|
Journal
|
Diagnostic microbiology and infectious disease
|
|
Journal Info
|
2011 Dec;71(4):396-402
|
|
Abstract
|
Pandemic 2009 H1N1 is normally susceptible to oseltamivir, but variants harboring the H275Y (CAC --> TAC) mutation exhibit resistance. We describe the use of a combined reverse-transcription polymerase chain reaction (RT-PCR)/pyrosequencing approach to identify the H275 residue. A total of 223 specimens were tested with this method: 216 randomly selected clinical specimens positive for 2009 H1N1 and 7 cell-culture supernatants from the Centers for Disease Control and Prevention (CDC; 4 resistant, 3 susceptible 2009 H1N1 strains). The assay detected H275Y in 1 clinical respiratory sample (0.5%) and all 4 oseltamivir-resistant strains from the CDC; the remaining 215 clinical and 3 susceptible CDC specimens were wild-type. Sanger sequencing confirmed the results for 50 of 50 selected isolates. The RT-PCR/pyrosequencing method was highly specific, producing no amplicons or valid sequences from samples containing non-H1N1 viruses or bacteria. Our findings suggest that this method provides a rapid tool for H275Y detection, with high sensitivity and potential benefit for patient care.
|
|
Sequence Data
|
-
|